O'Leary Timothy J
Department of Cellular Pathology and Genetics, Armed Forces Institute of Pathology, Washington, DC, USA.
Cancer. 2004 Dec 25;102(6):331-3. doi: 10.1002/cncr.20719.
The effectiveness of prescreening and rescreening cervical cytology preparations-whether used as quality assurance measures or in the attempt to improve sensitivity-has engendered broad discussion within the cytology community. This paper forms an introduction to some of the issues surrounding prescreening and rescreening in cervical cytology.